Senores Pharmaceuticals Limited (BOM:544319)
785.25
-17.50 (-2.18%)
At close: Feb 13, 2026
Senores Pharmaceuticals Company Description
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services.
The company was incorporated in 2017 and is based in Ahmedabad, India.
Senores Pharmaceuticals Limited
| Country | India |
| Founded | 2017 |
| Industry | Pharmaceutical Preparations |
| Employees | 194 |
| CEO | Swapnil Shah |
Contact Details
Address: South Tower Ahmedabad, Gujarat 380054 India | |
| Phone | 91 79 2999 9857 |
| Website | senorespharma.com |
Stock Details
| Ticker Symbol | 544319 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Swapnil Shah | Chief Executive Officer |
| Deval Shah | Chief Financial Officer |
| Chetan Shah | Chief Operating Officer |